The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer. [electronic resource]
- Immunobiology 02 2018
- 171-177 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-3279
10.1016/j.imbio.2017.10.029 doi
Acute-Phase Reaction--etiology Adult Aged Aged, 80 and over Antineoplastic Agents--adverse effects Bone Density Conservation Agents--adverse effects Bone Neoplasms--complications Breast Neoplasms--complications Diphosphonates--adverse effects Drug-Related Side Effects and Adverse Reactions--immunology Female Granzymes--metabolism HLA-DR Antigens--metabolism Humans Immunophenotyping Lymphocyte Activation--drug effects Male Middle Aged Perforin--metabolism Pilot Projects Prostatic Neoplasms--complications Receptors, Antigen, T-Cell, gamma-delta--metabolism Simvastatin--adverse effects T-Lymphocytes--physiology